Empowering Infectious Disease Diagnostics with Trusted Antibodies and Antigens

At Hytest, we are committed to advancing diagnostics through scientific precision and high-quality reagents. Our antibody solutions for infectious disease markers support accurate detection and monitoring — helping healthcare professionals make confident, timely decisions.

Infectious diseases remain a major global health challenge, requiring reliable tools for early diagnosis and outbreak control. Whether addressing long-established pathogens or emerging threats, the need for dependable and scalable diagnostics has never been greater.

This campaign features our trusted antibodies and antigen for infectious disease diagnostics. Explore the products below to discover how Hytest can support your development of sensitive and specific assays.

Thank you for choosing Hytest as your partner in diagnostic excellence.

To better serve our customers in diagnostics and research, we are expanding our infectious disease product portfolio with the launch of new HIV antibody and HCV antigen products. This strategic addition reflects our ongoing commitment to supporting the development of robust assays that enable early detection, better patient outcomes, and stronger global health responses.

Check our new product launches here. 

New HIV p24 Antibodies Launched
New Recombinant HCV NS3 Antigen

Our comprehensive offering now includes solutions for Influenza A & B, SARS-CoV-2, RSV, Hepatitis B, HPV, HIV, HCV and many others. Each reagent is manufactured to meet the highest standards of quality and performance. Explore below to find more!

Influenza A and B

Seasonal influenza affects millions each year, with Influenza A being responsible for global outbreaks and Influenza B for regional epidemics. Early and accurate detection
is essential for timely treatment and containment. Our products target key viral proteins to support the development of sensitive rapid tests and lab-based assays. 

SARS-CoV-2 

The virus behind COVID-19 has reshaped public health and diagnostic landscapes. With ongoing variants and long-term surveillance needs, dependable reagents are vital. Our SARS-CoV-2 product line includes high-affinity antibodies and antigens designed for immunoassay development. 

Respiratory Syncytial Virus (RSV) 

A leading cause of lower respiratory tract infections in infants and older adults, RSV presents a serious seasonal challenge. Rapid, point-of-care diagnosis can significantly reduce hospitalizations. Our RSV reagents support assay development for both clinical and surveillance applications. 

Hepatitis B Virus 

A global burden with over 250 million chronic carriers, hepatitis B can lead to severe liver disease, including cirrhosis and cancer. Early detection of HBV antigens and antibodies is crucial for screening, vaccination monitoring, and treatment decisions. We offer well-characterized reagents for HBV assay development. 

Human papillomavirus (HPV) 

A major cause of cervical and other cancers, HPV often progresses silently without early detection. Accurate diagnostics are key to prevention and early intervention. Our HPV antigens and antibodies are optimized for immunoassay-based detection platforms. 

Human Immunodeficiency Virus (HIV) 

Despite advances in treatment, HIV remains a major global health concern. Reliable diagnosis is critical for prevention, early care, and managing transmission. Our newly expanded HIV portfolio now includes high-quality antibodies, offering robust tools for both screening and confirmatory diagnostics. 

Hepatitis C Virus (HCV) 

HCV is a major cause of chronic liver disease worldwide, often progressing silently until advanced stages. Early detection is key to effective treatment and transmission control. Our high-quality HCV antigen supports the development of reliable assays for screening and confirmation. 

Other infectious disease products 

In addition to our core offerings, we also provide a selection of biomarkers for acute respiratory infections and foodborne pathogens. These products enhance the breadth of our infectious disease portfolio, helping to deliver a more comprehensive approach to infectious disease diagnostics.  

Read more about our infectious disease products in Infectious Disease Brochure. 

*Terms: The special offer opportunity is only available to end users. Institutes and universities are not included in this promotion. The usual shipping and handling costs will still apply. When ordering online, write infectious to the remarks field and select invoice or prepayment invoice as a payment method on the checkout page. The opportunity is a one-time evaluation possibility, feedback about the evaluation results is expected and you can get more details by contacting Hytest customer service at hytest@hytest.fi. Please be informed that research samples provided free of charge may be subject to taxes and duties in some countries. The campaign is not valid for antigens, except Cat# 8HC53, HCV antigen.

Do you need samples?

We are happy to make you an offer